Scholay

学术搜索 · AI 审稿 · LaTeX 协作

Advancing Transthyretin Amyloidosis Drug Development in an Evolving Treatment Landscape: Amyloidosis Forum Meeting Proceedings

作者:Mathew S. Maurer, Prem Soman, Adrian F. Hernandez, Pablo García‐Pavía, James Signorovitch, L. J. Wei, Mazen Hanna, Frederick L. Ruberg, M. Kittleson, Dhruv S. Kazi, Sharmila Dorbala, Kristen Hsu, Isabelle Lousada, Rosalyn Adigun, Preston Dunnmon, Jeffery W. Kelly, Julian D. Gillmore, the Amyloidosis Forum Meeting Panelists, Ahmad Masri, Alanna A. Morris, Angela Dispenzieri, John L. Berk, Keith C. Ferdinand, Keyur B. Shah, Kristen McCausland, Lynnette Henshaw, Martha Grogan, Megan Azzarone, Michael Polydefkis, Mona Fiuzat, Renée P. Bullock-Palmer, Benjamin J. Booth, Charu Gandotra, Clemens Mittmann, Cynthia T. Welsh, Dalia Dawoud, Emmanouil Zouridakis, Francesca Cunningham, Jean‐Michel Race, Jie Li, Ken Sakushima, Laura Jawidzik, Michelle Campbell, Motiur Rahman, Norman Stockbridge, Rhea Lloyd, Robyn Bent, Sylvia Kuehn, Wiley Chambers, Andrew Slugg, Franca S. Angeli, Johnathan Fox, Martín Cowie, Matt Meldorf, Michael L. Maitland, Michael S. Roberts, Michele Mercuri, Sam Tsimikas, Victoria Sanjurjo · 发表于:Advances in Therapy · 年份:2024 · DOI:10.1007/s12325-024-02891-0 · 被引用次数:7 · 研究领域:Amyloidosis: Diagnosis, Treatment, Outcomes、Alzheimer's disease research and treatments、Multiple Myeloma Research and Treatments